| Canadian start-up Innovative Trauma Care, which has developed a hemorrhage-control device, announced Tuesday that the company has raised $3.64 million in a Series A funding round.The money will be used to commercialize the company’s first product – the ITClamp Hemorrhage Control System – in Canada, and also in Europe and the U.S., once ITC wins regulatory clearance in those markets. The regulatory go-ahead is expected for both markets in early 2013. Investors in the round were not disclosed, although the city of San Antonio’s Economic Development Corporation is an investor.The ITClamp aims to control severe bleeding in as little as five seconds by sealing the skin closed to create a temporary clot that provides stability until the wound can be surgically repaired, according to the company’s news release.
Management of bleeding after severe trauma is critical because uncontrolled trauma bleeding is one of the foremost causes for preventable deaths among trauma patients. Others are at risk of of multiple organ failure. ITC is founded and led by Dr. Dennis Filips, a veteran of the Canadian military. |
|
